Evidence map›Paper›PMID 30091476›Full record

ReviewThe Journal of physiology2019

Sensors and signals: the role of reactive oxygen species in hypoxic pulmonary vasoconstriction.

Kimberly A Smith, Paul T Schumacker

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Mechanisms Underlying Altitude-Induced and Group 3 Pulmonary Hypertension.International journal of molecular sciences · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Generation of Reactive Oxygen Species by Mitochondria.Antioxidants (Basel, Switzerland) · 2021
    Review
  15. Article
  16. Review
  17. Article
  18. Recombinant Human Superoxide Dismutase andMolecules (Basel, Switzerland) · 2019
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kimberly A SmithDepartment of Pediatrics, Division of Neonatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Paul T SchumackerDepartment of Pediatrics, Division of Neonatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.ORCID 0000-0001-9591-2034
Northwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

When lung cells experience hypoxia, the functional response, termed hypoxic pulmonary vasoconstriction, activates a multitude of pathways with the goal of optimizing gas exchange. While previously controversial, overwhelming evidence now suggests that increased reactive oxygen species - produced at complex III of the mitochondrial electron transport chain and released into the intermembrane space - is the cellular oxygen signal responsible for triggering hypoxic pulmonary vasoconstriction. The increased reactive oxygen species (ROS) activate many downstream targets that ultimately lead to increased intracellular ionized calcium concentration and contraction of pulmonary arterial smooth muscle cells. While the specific targets of ROS signals are not completely understood, it is clear that this signalling pathway is critical for development and for normal lung function in newborns and adults.

Indexed as

VasoconstrictionAnimalsBlood VesselsHumansHypoxiaLungReactive Oxygen SpeciesSignal TransductionReactive Oxygen Specieshypoxiamitochondriapulmonary circulationpulmonary hypertensionredox signaling

Identifiers

PMID30091476
PMCPMC6375867
OpenAlexW2894677876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.